Unexpected roles of phosphoinositides in the nucleus

磷酸肌醇在细胞核中的意外作用

基本信息

  • 批准号:
    10711033
  • 负责人:
  • 金额:
    $ 35.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2028-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT Phosphoinositides (PIs) are a minor class of phospholipids often comprising less than 1% of the cellular lipid cohort. Despite the low abundance, PIs have huge impacts on cell physiology and alterations of PI signaling pathways are associated with the pathogenesis of many human diseases including neurodegenerative diseases, metabolic disorders, autoimmunity, and cancer. This pathophysiological importance is largely due to the signaling roles of PIs which depend on the subcellular distribution of PIs and on key interactions between PIs and PI effectors. A twist in PI signaling is that in contrast to general belief, a substantial fraction of PIs is found in non-membranous nuclear compartments. The nature and functions of nuclear PIs remains largely unknown due to the lack of systematic studies of nuclear PIs and PI effectors. We have expertise in defining and characterizing novel PI effector proteins involved in key signaling pathways including vesicular trafficking, cytoskeleton dynamics, and transcription regulation. Since PI kinases are often associated with PI effectors thus ensuring PI generation is spatiotemporally linked to PI effector activation, we have performed proteomic analyses to identify the interactomes of the nuclear PI-generating kinases. Out of these proteomic screens, we have validated several nuclear complexes that associate with nuclear PI kinases or with PIs themselves. The validated complexes include transcription factors and coactivators, epigenetic enzymes and associated corepressors, the DNA repair machinery, and factors involved in RNA processing. We recently discovered that nuclear PIs accumulate at distinct subnuclear regions such as nuclear speckles and DNA double-strand breaks. Based on our novel discoveries of PIs and PI kinases interacting with effectors in the nucleus, the overarching goal of my research program is to decipher the signaling pathways emanating from the nuclear PIs. Our overall hypothesis is that upon suitable stimuli the activation of nuclear PI kinase at specific subnuclear compartments elevates the local concentration of nuclear PIs and these nuclear PI foci function as platforms to regulate PI effectors recruited to the foci mediating transcription regulation and assembly of complexes that regulate epigenetic changes. The goals of my research programs for the next five years include dissecting the nature and subnuclear distribution of nuclear PIs using novel microscopic tools which will enable us to obtain high resolution images of the nuclear PIs, defining the new roles of PIs regulating chromatin positioning to nuclear speckles, and investigating novel roles of nuclear PIs in regulating gene expression with focuses on transcription regulation and epigenetic repression with innovative cell biological, genome-wide, and biochemical approaches. Upon the completion of the research programs, we will obtain insight into the unexpected roles and molecular mechanism of PIs in the nucleus, with the goal of identifying novel strategies for targeting the nuclear PI signaling pathways dysregulated in diverse human disease.
项目摘要 /摘要 磷酸肌醇(PIS)是一类少数磷脂,通常不到细胞脂质的1% 队列。尽管丰度较低,但PI对细胞生理和PI信号的改变有巨大影响 途径与许多人类疾病的发病机理有关,包括神经退行性疾病, 代谢疾病,自身免疫性和癌症。这种病理生理的重要性在很大程度上是由于 PI的信号传导作用,依赖于PI的亚细胞分布以及PI之间的关键相互作用 和PI效应子。 PI信号的扭曲是,与一般信念相比,发现很大一部分PI 在非膜核室中。核PI的性质和功能在很大程度上仍然未知 由于缺乏对核PI和PI效应子的系统研究。我们在定义和 表征参与关键信号通路的新型PI效应蛋白,包括囊泡运输, 细胞骨架动力学和转录调节。由于PI激酶通常与PI效应子相关 确保PI生成与PI效应子激活有空间链接,我们进行了蛋白质组学分析 确定核PI生成激酶的相互作用。在这些蛋白质组学屏幕中,我们有 验证了几个与核PI激酶或PI本身相关的核复合物。已验证 复合物包括转录因子和共激活剂,表观遗传酶和相关的核心, DNA修复机制以及RNA处理中涉及的因素。我们最近发现核pis 积聚在不同的亚核区域,例如核斑点和DNA双链断裂。基于 我们对PI和PI激酶的新发现与核中效应子相互作用,这是总体目标 我的研究计划是破译从核PI中发出的信号通路。我们的整体 假设是,在适当的刺激下,核PI激酶在特定的亚核腔室中的激活 提高核PI的局部浓度和这些核PI灶作为调节PI的平台的功能 募集到调节调节复合物的转录调节和组装的焦点的效应子 表观遗传变化。接下来五年我研究计划的目标包括剖析性质和 使用新型的微观工具对核PI的亚核分布,这将使我们能够获得高分辨率 核PI的图像,定义了调节染色质定位到核斑点的新作用的新作用, 并研究核PI在调节基因表达中的新作用,重点是转录调节 以及具有创新的细胞生物学,全基因组和生化方法的表观抑制作用。在 完成研究计划的完成,我们将深入了解意外角色和分子机制 核中的PI,目的是确定针对核PI信号通路的新型策略 在多种人类疾病中失调。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Suyong Choi的其他基金

PIP5K1A is a novel mutant KRAS effector and essential for pancreatic cancer cell survival
PIP5K1A 是一种新型突变型 KRAS 效应子,对于胰腺癌细胞的生存至关重要
  • 批准号:
    10666257
    10666257
  • 财政年份:
    2023
  • 资助金额:
    $ 35.67万
    $ 35.67万
  • 项目类别:
Novel Mechanisms of Nuclear Phosphoinositide Signaling in Regulation of the YAP/TAZ Pathway in Triple-negative Breast Cancer
核磷酸肌醇信号传导调节三阴性乳腺癌 YAP/TAZ 通路的新机制
  • 批准号:
    10579376
    10579376
  • 财政年份:
    2022
  • 资助金额:
    $ 35.67万
    $ 35.67万
  • 项目类别:
Novel Mechanisms of Nuclear Phosphoinositide Signaling in the Regulation of the YAP/TAZ Pathway in Triple-Negative Breast Cancer
核磷酸肌醇信号传导调节三阴性乳腺癌 YAP/TAZ 通路的新机制
  • 批准号:
    10714241
    10714241
  • 财政年份:
    2018
  • 资助金额:
    $ 35.67万
    $ 35.67万
  • 项目类别:

相似国自然基金

超声驱动压电薄膜刺激迷走神经治疗自身免疫性心肌炎及机制研究
  • 批准号:
    82302227
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PEBP4通过下调TRAF6泛素化抑制自身免疫性慢性非细菌性前列腺炎的作用及机制研究
  • 批准号:
    82360155
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
靶向T细胞的工程化间充质干细胞小细胞内囊泡治疗自身免疫性葡萄膜炎的研究
  • 批准号:
    82371044
  • 批准年份:
    2023
  • 资助金额:
    46 万元
  • 项目类别:
    面上项目
氨基酸感应器GCN2调控Beclin-1介导的自噬缓解自身免疫性甲状腺炎的作用研究
  • 批准号:
    82370792
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
索拉非尼通过诱导调节性T细胞抑制自身免疫性疾病的研究
  • 批准号:
    32370955
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Underdiagnosis of primary immunodeficiency disorders among racial and ethnic minorities: Recognize and Educate
少数种族和族裔中原发性免疫缺陷病的诊断不足:认识和教育
  • 批准号:
    10706597
    10706597
  • 财政年份:
    2022
  • 资助金额:
    $ 35.67万
    $ 35.67万
  • 项目类别:
Underdiagnosis of primary immunodeficiency disorders among racial and ethnic minorities: Recognize and Educate
少数种族和族裔中原发性免疫缺陷病的诊断不足:认识和教育
  • 批准号:
    10533223
    10533223
  • 财政年份:
    2022
  • 资助金额:
    $ 35.67万
    $ 35.67万
  • 项目类别:
9th Annual meeting of the International Cytokine and Interferon Society Meeting
国际细胞因子和干扰素学会第九届年会
  • 批准号:
    10389980
    10389980
  • 财政年份:
    2021
  • 资助金额:
    $ 35.67万
    $ 35.67万
  • 项目类别:
The Immunopathogenic role of XIST in Sjogren's Syndrome
XIST 在干燥综合征中的免疫致病作用
  • 批准号:
    9979575
    9979575
  • 财政年份:
    2020
  • 资助金额:
    $ 35.67万
    $ 35.67万
  • 项目类别:
The 4th Annual Meeting of the International Cytokine and Interferon Society (ICIS)
国际细胞因子和干扰素学会(ICIS)第四届年会
  • 批准号:
    9194798
    9194798
  • 财政年份:
    2016
  • 资助金额:
    $ 35.67万
    $ 35.67万
  • 项目类别: